Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
Inoue A, Nishikawa M, Ohnishi T, Yano H, Kanemura Y, Ohtsuka Y, Ozaki S, Nakamura Y, Matsumoto S, Suehiro S, Yamashita D, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T. Inoue A, et al. Among authors: kanemura y. World Neurosurg. 2021 Sep;153:e76-e95. doi: 10.1016/j.wneu.2021.06.044. Epub 2021 Jun 16. World Neurosurg. 2021. PMID: 34144167
Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.
Kanemura Y, Mori K, Sakakibara S, Fujikawa H, Hayashi H, Nakano A, Matsumoto T, Tamura K, Imai T, Ohnishi T, Fushiki S, Nakamura Y, Yamasaki M, Okano H, Arita N. Kanemura Y, et al. Differentiation. 2001 Sep;68(2-3):141-52. doi: 10.1046/j.1432-0436.2001.680208.x. Differentiation. 2001. PMID: 11686236
Diagnostic Performance of [11C]Methionine Positron Emission Tomography in Newly Diagnosed and Untreated Glioma Based on the Revised World Health Organization 2016 Classification.
Nakajo K, Uda T, Kawashima T, Terakawa Y, Ishibashi K, Tsuyuguchi N, Tanoue Y, Nagahama A, Uda H, Koh S, Sasaki T, Ohata K, Kanemura Y, Goto T. Nakajo K, et al. Among authors: kanemura y. World Neurosurg. 2021 Apr;148:e471-e481. doi: 10.1016/j.wneu.2021.01.012. Epub 2021 Jan 11. World Neurosurg. 2021. PMID: 33444827
CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma.
Nishikawa M, Inoue A, Ohnishi T, Yano H, Kanemura Y, Kohno S, Ohue S, Ozaki S, Matsumoto S, Suehiro S, Nakamura Y, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T. Nishikawa M, et al. Among authors: kanemura y. Cancer Med. 2021 Mar;10(6):2013-2025. doi: 10.1002/cam4.3767. Epub 2021 Feb 5. Cancer Med. 2021. PMID: 33543833 Free PMC article.
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma.
Nishikawa M, Inoue A, Ohnishi T, Yano H, Ozaki S, Kanemura Y, Suehiro S, Ohtsuka Y, Kohno S, Ohue S, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T. Nishikawa M, et al. Among authors: kanemura y. Transl Oncol. 2021 Aug;14(8):101137. doi: 10.1016/j.tranon.2021.101137. Epub 2021 May 27. Transl Oncol. 2021. PMID: 34052625 Free PMC article.
Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy.
Nakamura Y, Inoue A, Nishikawa M, Ohnishi T, Yano H, Kanemura Y, Ohtsuka Y, Ozaki S, Kusakabe K, Suehiro S, Yamashita D, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T. Nakamura Y, et al. Among authors: kanemura y. Acta Neurochir (Wien). 2022 Dec;164(12):3253-3266. doi: 10.1007/s00701-022-05363-y. Epub 2022 Sep 15. Acta Neurochir (Wien). 2022. PMID: 36107232
215 results